{"id":"https://openalex.org/W3033565404","doi":"https://doi.org/10.1186/s13045-020-00905-2","title":"Evolving therapy of adult acute lymphoblastic leukemia: state-of-the-art treatment and future directions","display_name":"Evolving therapy of adult acute lymphoblastic leukemia: state-of-the-art treatment and future directions","alternate_titles":[],"publication_year":2020,"publication_date":"2020-06-05","ids":{"openalex":"https://openalex.org/W3033565404","doi":"https://doi.org/10.1186/s13045-020-00905-2","mag":"3033565404","pmid":"https://pubmed.ncbi.nlm.nih.gov/32503572","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7275444"},"language":"en","primary_location":{"id":"doi:10.1186/s13045-020-00905-2","doi":"https://doi.org/10.1186/s13045-020-00905-2","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s13045-020-00905-2","pdf_url":"https://jhoonline.biomedcentral.com/counter/pdf/10.1186/s13045-020-00905-2","source":{"id":"https://openalex.org/S46507181","display_name":"Journal of Hematology & Oncology","issn_l":"1756-8722","issn":["1756-8722"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Hematology &amp; Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3033565404"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jhoonline.biomedcentral.com/counter/pdf/10.1186/s13045-020-00905-2","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5022932599","display_name":"Bachar Samra","orcid":"https://orcid.org/0000-0002-8838-9350","observed_orcids":["https://orcid.org/0000-0002-8838-9350"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Bachar Samra","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049385583","display_name":"Elias Joseph Jabbour","orcid":"https://orcid.org/0000-0003-4465-6119","observed_orcids":["https://orcid.org/0000-0003-4465-6119"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Elias Jabbour","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000750846","display_name":"Farhad Ravandi","orcid":"https://orcid.org/0000-0002-7621-377X","observed_orcids":["https://orcid.org/0000-0002-7621-377X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Farhad Ravandi","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090435894","display_name":"Hagop M. Kantarjian","orcid":"https://orcid.org/0000-0002-1908-3307","observed_orcids":["https://orcid.org/0000-0002-1908-3307"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hagop Kantarjian","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5091492845","display_name":"Nicholas James Short","orcid":"https://orcid.org/0000-0002-2983-2738","observed_orcids":["https://orcid.org/0000-0002-2983-2738"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Nicholas J. Short","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. NShort@mdanderson.org","Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA"],"raw_orcid":"https://orcid.org/0000-0002-2983-2738","affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. NShort@mdanderson.org","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5091492845"],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":{"value":3790,"currency":"USD","value_usd":3790},"apc_paid":{"value":3790,"currency":"USD","value_usd":3790},"fwci":4.565,"has_fulltext":true,"cited_by_count":196,"citation_normalized_percentile":{"value":0.9755002,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":100},"biblio":{"volume":"13","issue":"1","first_page":"70","last_page":"70"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adult-acute-lymphoblastic-leukemia","display_name":"adult acute lymphoblastic leukemia","score":0.9940000176429749},{"id":"https://openalex.org/keywords/measurable-residual-disease","display_name":"minimal residual disease","score":0.968999981880188},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.921999990940094},{"id":"https://openalex.org/keywords/bcr-abl1","display_name":"BCR-ABL1","score":0.9940000176429749},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.9879999756813049},{"id":"https://openalex.org/keywords/inotuzumab-ozogamicin","display_name":"inotuzumab ozogamicin","score":0.9330000281333923},{"id":"https://openalex.org/keywords/cd22","display_name":"CD22","score":0.75},{"id":"https://openalex.org/keywords/blinatumomab","display_name":"blinatumomab","score":0.9369999766349792},{"id":"https://openalex.org/keywords/bispecific-antibodies","display_name":"bispecific antibodies","score":0.8790000081062317},{"id":"https://openalex.org/keywords/tisagenlecleucel","display_name":"tisagenlecleucel","score":0.875},{"id":"https://openalex.org/keywords/cd19-car-t-cell-therapy","display_name":"CD19 CAR T-cell therapy","score":0.7369999885559082},{"id":"https://openalex.org/keywords/hematopoietic-stem-cell-transplantation","display_name":"hematopoietic stem cell transplantation","score":0.8989999890327454},{"id":"https://openalex.org/keywords/prognostic-model","display_name":"prognostic model","score":0.7649999856948853}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7816407084465027},{"id":"https://openalex.org/C194409129","wikidata":"https://www.wikidata.org/wiki/Q103824","display_name":"Hematology","level":2,"score":0.7472755312919617},{"id":"https://openalex.org/C2909962599","wikidata":"https://www.wikidata.org/wiki/Q180664","display_name":"Lymphoblastic Leukemia","level":3,"score":0.7034863829612732},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4903688430786133},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.47903457283973694},{"id":"https://openalex.org/C2781107101","wikidata":"https://www.wikidata.org/wiki/Q180664","display_name":"Acute lymphocytic leukemia","level":4,"score":0.47233882546424866},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.41471758484840393},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.35959386825561523},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.35657161474227905}],"mesh":[{"descriptor_ui":"D000066491","descriptor_name":"Clinical Decision-Making","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000074322","descriptor_name":"Antineoplastic Agents, Immunological","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000080045","descriptor_name":"Inotuzumab Ozogamicin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000367","descriptor_name":"Age Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005544","descriptor_name":"Forecasting","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009363","descriptor_name":"Neoplasm Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D010677","descriptor_name":"Philadelphia Chromosome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011948","descriptor_name":"Receptors, Antigen, T-Cell","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015507","descriptor_name":"Drugs, Investigational","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016044","descriptor_name":"Fusion Proteins, bcr-abl","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D016219","descriptor_name":"Immunotherapy, Adoptive","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017254","descriptor_name":"Leukemic Infiltration","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D018033","descriptor_name":"Antibodies, Bispecific","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D018380","descriptor_name":"Hematopoietic Stem Cell Transplantation","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":false},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D035703","descriptor_name":"Therapies, Investigational","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D054198","descriptor_name":"Precursor Cell Lymphoblastic Leukemia-Lymphoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D054198","descriptor_name":"Precursor Cell Lymphoblastic Leukemia-Lymphoma","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058990","descriptor_name":"Molecular Targeted Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1186/s13045-020-00905-2","doi":"https://doi.org/10.1186/s13045-020-00905-2","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s13045-020-00905-2","pdf_url":"https://jhoonline.biomedcentral.com/counter/pdf/10.1186/s13045-020-00905-2","source":{"id":"https://openalex.org/S46507181","display_name":"Journal of Hematology & Oncology","issn_l":"1756-8722","issn":["1756-8722"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Hematology &amp; Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7275444","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC7275444/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Hematol Oncol","raw_type":"Text"},{"id":"pmid:32503572","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32503572","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of hematology & oncology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:cf55ea0bebc542e49d806a008867ad38","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/cf55ea0bebc542e49d806a008867ad38","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Hematology & Oncology, Vol 13, Iss 1, Pp 1-17 (2020)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1186/s13045-020-00905-2","doi":"https://doi.org/10.1186/s13045-020-00905-2","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s13045-020-00905-2","pdf_url":"https://jhoonline.biomedcentral.com/counter/pdf/10.1186/s13045-020-00905-2","source":{"id":"https://openalex.org/S46507181","display_name":"Journal of Hematology & Oncology","issn_l":"1756-8722","issn":["1756-8722"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Hematology &amp; Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3033565404.pdf","grobid_xml":"https://content.openalex.org/works/W3033565404.grobid-xml"},"referenced_works_count":168,"referenced_works":["https://openalex.org/W7217595","https://openalex.org/W17959953","https://openalex.org/W1249635699","https://openalex.org/W1488000644","https://openalex.org/W1506738181","https://openalex.org/W1593530788","https://openalex.org/W1595924202","https://openalex.org/W1600925615","https://openalex.org/W1673031009","https://openalex.org/W1685744202","https://openalex.org/W1774142096","https://openalex.org/W1838408716","https://openalex.org/W1967348190","https://openalex.org/W1967512987","https://openalex.org/W1972060994","https://openalex.org/W1975280591","https://openalex.org/W1977336147","https://openalex.org/W1977380325","https://openalex.org/W1978302657","https://openalex.org/W1991343198","https://openalex.org/W1993808217","https://openalex.org/W1994482907","https://openalex.org/W1996697756","https://openalex.org/W1997434787","https://openalex.org/W2007234423","https://openalex.org/W2024540195","https://openalex.org/W2030796837","https://openalex.org/W2032346182","https://openalex.org/W2033862877","https://openalex.org/W2038613090","https://openalex.org/W2041353685","https://openalex.org/W2047522348","https://openalex.org/W2049000194","https://openalex.org/W2052739233","https://openalex.org/W2052846308","https://openalex.org/W2055886080","https://openalex.org/W2060605982","https://openalex.org/W2061585822","https://openalex.org/W2065851457","https://openalex.org/W2069709802","https://openalex.org/W2070394392","https://openalex.org/W2070520252","https://openalex.org/W2074464967","https://openalex.org/W2075101185","https://openalex.org/W2082105417","https://openalex.org/W2085453248","https://openalex.org/W2087090648","https://openalex.org/W2106275447","https://openalex.org/W2107925822","https://openalex.org/W2110056604","https://openalex.org/W2113231429","https://openalex.org/W2115482777","https://openalex.org/W2119967034","https://openalex.org/W2123755151","https://openalex.org/W2125233997","https://openalex.org/W2125486570","https://openalex.org/W2127226843","https://openalex.org/W2128478938","https://openalex.org/W2128491464","https://openalex.org/W2133182699","https://openalex.org/W2135492799","https://openalex.org/W2137042680","https://openalex.org/W2141795335","https://openalex.org/W2145662640","https://openalex.org/W2145822190","https://openalex.org/W2148202982","https://openalex.org/W2160248511","https://openalex.org/W2163878076","https://openalex.org/W2166295047","https://openalex.org/W2166306614","https://openalex.org/W2203215848","https://openalex.org/W2237775825","https://openalex.org/W2238009057","https://openalex.org/W2285218518","https://openalex.org/W2289642929","https://openalex.org/W2336673742","https://openalex.org/W2344488712","https://openalex.org/W2406225326","https://openalex.org/W2419639370","https://openalex.org/W2424740985","https://openalex.org/W2440705721","https://openalex.org/W2483008971","https://openalex.org/W2505271009","https://openalex.org/W2516611622","https://openalex.org/W2520695016","https://openalex.org/W2528412247","https://openalex.org/W2529791032","https://openalex.org/W2549717966","https://openalex.org/W2554580516","https://openalex.org/W2558112371","https://openalex.org/W2560140376","https://openalex.org/W2566332174","https://openalex.org/W2581891628","https://openalex.org/W2582784681","https://openalex.org/W2582896768","https://openalex.org/W2591709377","https://openalex.org/W2599899418","https://openalex.org/W2613210669","https://openalex.org/W2616269701","https://openalex.org/W2619897096","https://openalex.org/W2626936646","https://openalex.org/W2725721905","https://openalex.org/W2743267453","https://openalex.org/W2745344769","https://openalex.org/W2745522463","https://openalex.org/W2752517775","https://openalex.org/W2754648787","https://openalex.org/W2762869808","https://openalex.org/W2767124204","https://openalex.org/W2768823259","https://openalex.org/W2773570824","https://openalex.org/W2779241561","https://openalex.org/W2780760049","https://openalex.org/W2781552270","https://openalex.org/W2783032930","https://openalex.org/W2785018325","https://openalex.org/W2785037227","https://openalex.org/W2787145330","https://openalex.org/W2787301955","https://openalex.org/W2787621143","https://openalex.org/W2788740799","https://openalex.org/W2790062224","https://openalex.org/W2791923357","https://openalex.org/W2804546534","https://openalex.org/W2807974501","https://openalex.org/W2809629567","https://openalex.org/W2811207268","https://openalex.org/W2885940327","https://openalex.org/W2889648694","https://openalex.org/W2890201982","https://openalex.org/W2891640101","https://openalex.org/W2896845000","https://openalex.org/W2899217356","https://openalex.org/W2900007121","https://openalex.org/W2905241205","https://openalex.org/W2905654455","https://openalex.org/W2908746540","https://openalex.org/W2908892191","https://openalex.org/W2911262754","https://openalex.org/W2914373601","https://openalex.org/W2914705356","https://openalex.org/W2921153822","https://openalex.org/W2931981435","https://openalex.org/W2942680040","https://openalex.org/W2946805300","https://openalex.org/W2964177223","https://openalex.org/W2966952452","https://openalex.org/W2979686417","https://openalex.org/W2982831348","https://openalex.org/W2983067750","https://openalex.org/W2983205268","https://openalex.org/W2983342168","https://openalex.org/W2984670758","https://openalex.org/W2985453047","https://openalex.org/W2986209396","https://openalex.org/W2986316381","https://openalex.org/W2986868459","https://openalex.org/W2988562238","https://openalex.org/W2989074242","https://openalex.org/W2990608162","https://openalex.org/W2991073805","https://openalex.org/W3004611567","https://openalex.org/W3011093623","https://openalex.org/W3013694430","https://openalex.org/W3014584966","https://openalex.org/W3029174461","https://openalex.org/W3063038225","https://openalex.org/W4230895638"],"related_works":["https://openalex.org/W3027763907","https://openalex.org/W4410079860","https://openalex.org/W2946449338","https://openalex.org/W2921189497","https://openalex.org/W7167358945","https://openalex.org/W4225313092","https://openalex.org/W2094483830","https://openalex.org/W4408123260","https://openalex.org/W4409994712","https://openalex.org/W2890864006"],"abstract_inverted_index":{"Recent":[0],"years":[1],"have":[2,7,41],"witnessed":[3],"major":[4],"advances":[5,109],"that":[6,86],"improved":[8],"outcome":[9],"of":[10,19,22,39,47],"adults":[11],"with":[12,44],"acute":[13],"lymphoblastic":[14],"leukemia":[15],"(ALL).":[16],"The":[17,36],"emergence":[18],"the":[20,45,107],"concept":[21],"measurable":[23],"residual":[24],"disease":[25],"has":[26],"fine-tuned":[27],"our":[28,33],"prognostic":[29],"models":[30],"and":[31,67,93,110],"guided":[32],"treatment":[34,37],"decisions.":[35],"paradigms":[38],"ALL":[40],"been":[42],"revolutionized":[43],"advent":[46],"tyrosine":[48],"kinase":[49],"inhibitors":[50],"targeting":[51,55,60],"BCR-ABL1,":[52],"monoclonal":[53],"antibodies":[54,65],"CD20":[56],"(rituximab),":[57],"antibody-drug":[58],"conjugates":[59],"CD22":[61],"(inotuzumab":[62],"ozogamicin),":[63],"bispecific":[64],"(blinatumomab),":[66],"CD19":[68],"chimeric":[69],"antigen":[70],"receptor":[71],"T":[72],"cell":[73,96],"therapy":[74],"(tisagenlecleucel).":[75],"These":[76],"highly":[77],"effective":[78],"new":[79],"agents":[80],"are":[81],"allowing":[82],"for":[83],"novel":[84,114],"approaches":[85],"reduce":[87],"reliance":[88],"on":[89,106],"intensive":[90],"cytotoxic":[91],"chemotherapy":[92],"hematopoietic":[94],"stem":[95],"transplantation":[97],"in":[98,113,117],"first":[99],"remission.":[100],"This":[101],"comprehensive":[102],"review":[103],"will":[104],"focus":[105],"recent":[108],"future":[111],"directions":[112],"therapeutic":[115],"strategies":[116],"adult":[118],"ALL.":[119]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3033565404","counts_by_year":[{"year":2026,"cited_by_count":17},{"year":2025,"cited_by_count":31},{"year":2024,"cited_by_count":30},{"year":2023,"cited_by_count":54},{"year":2022,"cited_by_count":34},{"year":2021,"cited_by_count":27},{"year":2020,"cited_by_count":3}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2020-06-12T00:00:00"}
